Cure8 news brief
Cure8 news brief
Blood antibody patterns that appear years before symptoms could eventually enable earlier identification of people at risk for Crohn’s disease or ulcerative colitis and help predict who may develop more complicated disease.
Patients with IBD or family history of IBD; clinicians monitoring at-risk individuals; researchers in IBD biomarkers and AI diagnostics.
This report summarizes findings presented at UEG Week 2026 showing that serum antibody profiling across hundreds of thousands of antigens revealed distinct immune signatures years before diagnosis.
The study sampled people who later developed Crohn’s disease or ulcerative colitis and matched controls, and used machine-learning models to classify future disease (reported AUCs ~0.90 for Crohn’s and ~0.84 for UC).
The antibody patterns included higher responses to herpesviruses and bacterial flagellin in future Crohn’s cases, and rising responses to herpesviruses and autoantigens in future UC cases, plus declining responses to some encapsulated bacteria as diagnosis approached.
These results are preliminary and were presented at a conference rather than as a peer-reviewed journal article; they suggest potential for blood-based biomarkers but do not yet establish clinical tests or change care.
Findings were reported at UEG Week 2026 and summarized by ScienceDaily. Conference presentations are preliminary and require peer-reviewed publication and external validation before clinical use.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.